{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:18:49Z","timestamp":1793305129277,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jhep.2015.02.039","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T01:46:16Z","timestamp":1429667176000},"page":"S15-S24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":610,"special_numbering":"S","title":["Hepatic fibrosis: Concept to treatment"],"prefix":"10.1016","volume":"62","author":[{"given":"Christian","family":"Trautwein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.02.039_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.02.039_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.02.039_b0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/egh.10.47","article-title":"Update on the pathophysiology of liver fibrosis","volume":"4","author":"Pinzani","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.02.039_b0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0074-7696(08)61977-4","article-title":"Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs","volume":"66","author":"Wake","year":"1980","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.jhep.2015.02.039_b0030","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2015.02.039_b0035","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1074\/jbc.M113.543769","article-title":"Transcriptional repression of the transforming growth factor \u03b2 (TGF-\u03b2) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor \u03baB (NF-\u03baB) p50 enhances TGF-\u03b2 signaling in hepatic stellate cells","volume":"289","author":"Liu","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.039_b0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-1536-1-5","article-title":"Redox mechanisms in hepatic chronic wound healing and fibrogenesis","volume":"1","author":"Novo","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jhep.2015.02.039_b0045","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver: the mist gradually clear","volume":"48","author":"De Alwis","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2015.02.039_b0405","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1186\/1755-1536-5-S1-S27","article-title":"Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo","volume":"5","author":"Tacke","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jhep.2015.02.039_b0060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.02.039_b0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0070","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0075","doi-asserted-by":"crossref","first-page":"G571","DOI":"10.1152\/ajpgi.00537.2004","article-title":"Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells","volume":"289","author":"Brun","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.02.039_b0080","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0085","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.2353\/ajpath.2007.060887","article-title":"Vascular endothelial growth factor and angiopoietin-1 as hypoxia-dependent autocrine and paracrine factors stimulating migration and chemotaxis of activated human hepatic stellate cells","volume":"170","author":"Novo","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.02.039_b0090","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2012.07.115","article-title":"Hedgehog controls hepatic stellate cell fate by regulating metabolism","volume":"143","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0095","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.27131","article-title":"Epigenetics in liver disease","volume":"60","author":"Mann","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0100","doi-asserted-by":"crossref","first-page":"G110","DOI":"10.1152\/ajpgi.00412.2010","article-title":"Hepatic stellate cells require a stiff environment for myofibroblastic differentiation","volume":"301","author":"Olsen","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.02.039_b0105","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.02.039_b0110","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0168-8278(96)80265-0","article-title":"Pyridinoline collagen cross-links in patients with chronic viral hepatitis and cirrhosis","volume":"24","author":"Hayasaka","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0115","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0120","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2005.082701","article-title":"Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans","volume":"55","author":"Novo","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.02.039_b0125","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment","volume":"16","author":"Barry-Hamilton","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2015.02.039_b0130","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0168-8278(12)60008-7","article-title":"Antifibrotic therapy: lost in translation?","volume":"56","author":"Schuppan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0135","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.02.039_b0140","doi-asserted-by":"crossref","unstructured":"Mehal WZ, Schuppan D. Antifibrotic therapies: Moving towards clinical translation. Semin Liver Dis 2015.","DOI":"10.1055\/s-0035-1550055"},{"key":"10.1016\/j.jhep.2015.02.039_b0145","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.02.039_b0150","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis","volume":"56","author":"D\u2019Ambrosio","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0155","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1053\/j.gastro.2009.12.003","article-title":"Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection","volume":"138","author":"McHutchison","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0160","article-title":"Toward an integrated pipeline for protein biomarker development","author":"Drabovich","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2015.02.039_b0165","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.02.039_b0170","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Popov","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0175","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2014.08.013","article-title":"Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C","volume":"62","author":"Simon","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0185","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","article-title":"Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice","volume":"147","author":"Yoshida","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0190","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1053\/j.gastro.2007.02.033","article-title":"Gene expression profiles during hepatic stellate cell activation in culture and in vivo","volume":"132","author":"De Minicis","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0195","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1191035","article-title":"Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture","volume":"329","author":"Gilbert","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jhep.2015.02.039_b0200","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2009.05.005","article-title":"The elastic modulus of Matrigel\u2122 as determined by atomic force microscopy","volume":"167","author":"Soofi","year":"2009","journal-title":"J Struct Biol"},{"key":"10.1016\/j.jhep.2015.02.039_b0205","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10439-005-8159-4","article-title":"Mechanobiology in the third dimension","volume":"33","author":"Pedersen","year":"2005","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.jhep.2015.02.039_b0210","first-page":"380","article-title":"Fibroblasts and the ground they walk on","volume":"28","author":"Tschumperlin","year":"2013","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.jhep.2015.02.039_b0215","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.yexcr.2013.07.001","article-title":"In the beginning there were soft collagen-cell gels: towards better 3D connective tissue models?","volume":"319","author":"Brown","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jhep.2015.02.039_b0220","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.yexcr.2013.05.003","article-title":"Fibroblast morphogenesis on 3D collagen matrices: the balance between cell clustering and cell migration","volume":"319","author":"da Rocha-Azevedo","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jhep.2015.02.039_b0225","first-page":"59A","article-title":"Decellularized human Liver as a natural 3D scaffold for organ Engineering and 3D-disease modelling","volume":"60","author":"Mazza","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0230","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0235","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1053\/j.gastro.2011.01.040","article-title":"Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice","volume":"140","author":"Popov","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0240","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/jhep.2003.50196","article-title":"Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis","volume":"37","author":"Ueberham","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0245","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice","volume":"45","author":"Czochra","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0250","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1073\/pnas.0409722102","article-title":"Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma","volume":"102","author":"Campbell","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2015.02.039_b0255","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jhep.2013.01.009","article-title":"Precision-cut liver slices: a tool to model the liver ex vivo","volume":"58","author":"Olinga","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0260","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2015.02.039_b0265","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jhep.2014.02.031","article-title":"Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome","volume":"61","author":"Huang","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0270","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0275","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2036.2011.04765.x","article-title":"Liver stiffness diminishes with antiviral response in chronic hepatitis C","volume":"34","author":"Hezode","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.02.039_b0280","article-title":"Effects of bariatric surgery on severe liver injury in morbid obese patients with proven NASH: a prospective study","volume":"60","author":"Lassailly","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0285","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3748\/wjg.v11.i19.2892","article-title":"Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B","volume":"11","author":"Liu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.02.039_b0290","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. The","volume":"330","author":"Poupon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.02.039_b0295","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","article-title":"The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis","volume":"32","author":"Corpechot","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0300","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1478-3231.2012.02774.x","article-title":"Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis \u2013 a randomized open-label controlled study","volume":"32","author":"Kim","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.02.039_b0305","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.02.039_b0310","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0315","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.02.039_b0320","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/hep.23270","article-title":"Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial","volume":"51","author":"Ratziu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0325","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.24544","article-title":"Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial","volume":"54","author":"Zein","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0330","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.24558","article-title":"Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial","volume":"54","author":"Torres","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0335","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","article-title":"A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis","volume":"54","author":"Ratziu","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0340","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","author":"Neuschwander-Tetri","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.02.039_b0345","article-title":"Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension","author":"Procopet","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0350","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2013.12.016","article-title":"Role of magnetic resonance elastography in compensated and decompensated liver disease","volume":"60","author":"Asrani","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0355","first-page":"33","article-title":"The mean values of liver stiffness assessed by Acoustic Radiation Force Impulse elastography in normal subjects","volume":"13","author":"Popescu","year":"2011","journal-title":"Med Ultrason"},{"key":"10.1016\/j.jhep.2015.02.039_b0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","article-title":"Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease","volume":"60","author":"Banerjee","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0365","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2013.06.026","article-title":"Molecular MRI of collagen to diagnose and stage liver fibrosis","volume":"59","author":"Fuchs","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0370","doi-asserted-by":"crossref","first-page":"G1695","DOI":"10.1152\/ajpgi.00209.2006","article-title":"Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions","volume":"292","author":"Gardner","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.02.039_b0375","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/hep.24752","article-title":"Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial","volume":"55","author":"Everson","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.039_b0380","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2893.2008.01007.x","article-title":"A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT","volume":"15","author":"Lalazar","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2015.02.039_b0385","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/clpt.2014.113","article-title":"Accelerating drug development through collaboration: the hepatitis C drug development advisory group","volume":"96","author":"Hutchison","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.02.039_b0390","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.02.039_b0395","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.039_b0400","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781500149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781500149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T18:38:06Z","timestamp":1566585486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882781500149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S016882781500149X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.02.039","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725462503.793514217","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic fibrosis: Concept to treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}